Semaglutide is a glucagon-like peptide (GLP-1) that has shown to help with weightless by decreasing appetite, improved control of eating, reduced food cravings and improved glycemic control. The addition of B6 helps reduce the most common side effect, nausea.

Terzepatide is similar to Semaglutide in that it reduces cravings and decreases appetite. The difference is that semaglutide is a GLP-1 agonist, and tirzepatide mimics the GLP-1 and GIP hormones. GIP hormone can trigger insulin creation and provide a sensation of fullness